FAST NEWS: CanSino’s quarterly revenue rises, but loss also widens
The Latest: CanSino Biologics Inc. (6185.HK; 688185.SH) reported Monday its revenue rose 13.7% year-on-year to about 114 million yuan ($15.7 million) in the first quarter, while its net loss widened 21.9% to…
China’s mRNA pioneer Stemirna faces post-Covid reinvention test
The biopharma company that led the way in Chinese mRNA research is battling a wave of lawsuits and financial woes, including court limits on its founder’s spending Key Takeaways: Flush…
FAST NEWS: CanSino receives Gates Foundation grant to develop polio vaccine
The latest: CanSino Biologics Inc. (6185.HK; 688185.SH) announced on Tuesday it has entered into a grant agreement with the Bill & Melinda Gates Foundation, which will provide over $2 million to support…
Debt pressures cast cloud over Fosun Pharma results
The drugmaker eked out a 0.16% rise in first-half revenue, but underlying net profit slipped 26% as waning sales of Covid treatments and foreign exchange losses squeezed earnings Key Takeaways:…
With healthier finances, Clover Bio shifts to flu and RSV vaccines
The Chinese vaccine developer rebounded from a deep loss into profit in the first half of the year, boosted by a one-off gain from a Covid research grant Key Takeaways:…
Fosun Pharma, CanSino take different paths as Covid lift fade
The pair of companies that got strong shots from different Covid vaccines are telling different stories in their latest quarterly results as the pandemic draws down Key Takeaways: Fosun Pharma’s…
Innovative drugs soothe Fosun Pharma from pain of fading Covid vaccine
With China's pandemic controls ending and the WHO adjusting its vaccination recommendations, demand for the company’s comirnaty vaccine is plunging Key takeaways: Fosun Pharma's net profit fell more than 20%…
Recent Articles
FAST NEWS: CanSino’s quarterly revenue rises, but loss also widens
6185.HK
688185.SHG
FAST NEWS: CanSino receives Gates Foundation grant to develop polio vaccine
6185.HK
688185.SHG
Debt pressures cast cloud over Fosun Pharma results
2196.HK
600196.SHG
Fosun Pharma, CanSino take different paths as Covid lift fade
2196.HK
6185.HK
Innovative drugs soothe Fosun Pharma from pain of fading Covid vaccine
2196.HK
600196.SHG
RELATED ARTICLES
-
With healthier finances, Clover Bio shifts to flu and RSV vaccines
2197.HK
- Health Guard plans dual listing to fund HPV vaccine fight
- China’s mRNA pioneer Stemirna faces post-Covid reinvention test
-
FAST NEWS: CanSino’s revenue plunges as demand dries up for Covid vaccines
6185.HK 688185.SHG
-
FAST NEWS: CanSino receives Gates Foundation grant to develop polio vaccine
6185.HK 688185.SHG
